SEC Form 4 · accession 0001209191-17-008727
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harold C Flynn Jr.
Officer — President and CEO · Director
Period of report
Feb 6, 2017
Accepted (ET)
Feb 8, 2017 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Feb 6, 2017 | A | 1,000,000 | A | — | — | Common Stock | 1,000,000 | 1,464,761 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- F2The restricted stock units vest as follows: (i) one-quarter of the restricted stock units vest on the two-year anniversary of the award date, (ii) one-eighth of the restricted stock units vest on the three-year anniversary of the award date, (iii) one-eighth of the restricted stock units vest on the fourth-year anniversary of the award date, and (iv) one-half of the restricted stock units vest based upon specific performance criteria, subject to the Reporting Person's continued service with the Company through the applicable vesting dates.